DD vs PLRX · P/E 127, rev $12.39B vs $77.3M cap
Dupont De Nemours Inc (DD) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the DD and PLRX stock pages for the full models.
Not investment advice.